Opendata, web and dolomites

GLAUrious SIGNED

External Automatic Glaucoma Laser (EAGLE) for the first-line glaucoma treatment: Commercial prototype development and validation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GLAUrious project word cloud

Explore the words cloud of the GLAUrious project. It provides you a very rough idea of what is the project "GLAUrious" about.

hospitals    reducing    deterioration    glaurious    consequently    smes    50    belgium    causing    eye    validation    nerve    distributors    disseminating    optimizing    press    glaucoma    serious    procedure       first    specialists    prototype    opinion    chronic    ease    progression    incorporates    strategy    penetration    irreversible    refining    people    expertise    external    population    boosting    worldwide    delayed    multidisciplinary    lasts    212    daily    safely    ophthalmic    contact    intraocular    minute    globally    laser    minus    treatment    degeneration    academic    drop    pressure    primary    compliance    leaders    device    mci    commercialization    million    blindness    israel    securing    market    drops    disease    automated    industrial    automatic    painless    clinical    effect    accessible    uk    strict    bel    button    accessibility    ophthalmologists    dropout    patient    commercial    suffer    preventing    world    invasive    incurable    eagle    streamlining    line    regimen    revolutionary    optic    64    repeatable    overcoming    italy    progressive   

Project "GLAUrious" data sheet

The following table provides information about the project.

Coordinator
THE QUEEN'S UNIVERSITY OF BELFAST 

Organization address
address: UNIVERSITY ROAD LANYON BUILDING
city: BELFAST
postcode: BT7 1NN
website: www.qub.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.glaurious.eu
 Total cost 4˙036˙138 €
 EC max contribution 2˙480˙275 € (61%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2. (PRIORITY 'Industrial leadership')
 Code Call H2020-FTIPilot-2015-1
 Funding Scheme IA
 Starting year 2016
 Duration (year-month-day) from 2016-09-01   to  2020-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE QUEEN'S UNIVERSITY OF BELFAST UK (BELFAST) coordinator 261˙791.00
2    BELKIN LASER LTD IL (YAVNE) participant 1˙575˙658.00
3    UNIVERSITA DEGLI STUDI DI GENOVA IT (GENOVA) participant 264˙682.00
4    MAZO VSEVOLOD DE (FRIEDRICHSDORF) participant 190˙894.00
5    MEDICAL CONSULTING AND INVESTMENT BE (MELSELE) participant 187˙250.00

Map

 Project objective

The GLAUrious project is promoting the novel External Automatic Glaucoma Laser (EAGLE) device with the goal of providing accessible first-line treatment for glaucoma. Glaucoma, a chronic disease causing progressive optic nerve degeneration, is the leading cause of irreversible blindness globally. Although incurable, disease progression is delayed by reducing intraocular pressure, thus preventing blindness. Some 64 million people worldwide suffer from glaucoma. Current first-line treatment requires daily eye drops, a strict regimen causing 50% patient dropout after 1 year. Laser treatment for glaucoma has been in use for many years. Its effect lasts for 2−5 years and is repeatable. This traditional 10-minute procedure, involving contact with the patient’s eye, requires the expertise of glaucoma specialists. Consequently, costs are high and accessibility to the general population is low. The novel EAGLE procedure is automated, non-invasive, non-contact, painless and user friendly—1 second of treatment by one press of a button. This revolutionary cost-effective device could be safely used by the world’s 212,000 ophthalmologists, thus becoming a primary treatment for glaucoma, overcoming serious problems of eye drop non-compliance and effectively preventing disease deterioration. GLAUrious project aims to ease commercialization of the EAGLE device by securing clinical prototype validation, streamlining commercial production, optimizing component costs, disseminating to key opinion leaders and distributors, and refining commercial strategy. Validation of EAGLE will allow its commercialization enabling penetration of the ophthalmic market and boosting of the industrial consortium partners (BEL and MCI). The multidisciplinary GLAUrious Consortium, with its four partners from three member states (Belgium, Italy, UK) and one associated state (Israel), incorporates two SMEs and two academic hospitals.

 Deliverables

List of deliverables.
Report on study initiation and training of clinical sites Documents, reports 2020-01-23 08:41:31
Interim report 1 of patients\' recruitment, study implementation and clinical trial monitoring Documents, reports 2020-01-23 08:41:31
Quality control plan Documents, reports 2020-01-23 08:41:31
Demonstrational prototypes produced Demonstrators, pilots, prototypes 2020-01-23 08:41:31
Finalized clinical protocol and investigator brochure submitted Documents, reports 2020-01-23 08:41:31
Report on planned communication activities Documents, reports 2020-01-23 08:41:31
Updates to the risk mitigation strategy Documents, reports 2020-01-23 08:41:31
Public website Websites, patent fillings, videos etc. 2020-01-23 08:41:31

Take a look to the deliverables list in detail:  detailed list of GLAUrious deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLAURIOUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GLAURIOUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.)

Innovation Principle (2019)

Developing an Innovation-Friendly Legislative Culture – the Innovation Principle at Work

Read More  

PULSe (2017)

Pervasive Ubiquitous Lightwave SEnsor

Read More  

ShaleSafe (2016)

Development of a monitoring system for inspection of soil and aquifer contamination by shalegas and fracking chemicals

Read More